Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2012 16:15 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Announces Partial Exercise of Over-Allotment Option by Aegis Capital Corp.

NEW YORK, June 5, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the partial exercise of the...
May 15, 2012 09:15 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals to Present Abstract at Digestive Disease Week 2012

NEW YORK, May 15, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases, today...
May 09, 2012 16:15 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Announces Closing of Public Offering of 10,000,000 Shares of Common Stock

NEW YORK, May 9, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP),a developer of new drugs to treat gastrointestinal disorders and diseases, announced the closing of its...
May 04, 2012 01:52 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of 10,000,000 Shares of Common Stock

NEW YORK, May 4, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the pricing of an...
May 03, 2012 16:19 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Inc. Announces Proposed Public Offering

NEW YORK, May 3, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today its intention, subject...
May 02, 2012 04:00 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer

NEW YORK, May 2, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases,...
April 09, 2012 07:15 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Achieves Halfway Mark in Enrollment on Plecanatide Phase II/III Trial in Chronic Idiopathic Constipation

NEW YORK, April 9, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases, today...
March 26, 2012 07:30 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals to Present at AACR

NEW YORK, March 26, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that a poster...
March 21, 2012 07:30 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals to Present at the Maxim Group Growth Conference

NEW YORK, March 21, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYPD) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases,...
March 15, 2012 19:06 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Financial

NEW YORK, March 15, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases, today...